Information  X 
Enter a valid email address

Consort Medical Plc (CSRT)

  Print      Mail a friend       Annual reports

Thursday 06 December, 2018

Consort Medical Plc

Director/PDMR Shareholding

RNS Number : 7381J
Consort Medical PLC
06 December 2018
 

Consort Medical plc

Director Shareholding

6 December 2018

Consort Medical plc (the 'Company') announces that Paul Hayes, Chief Financial Officer purchased 4,000 ordinary 10p shares at an aggregated price of £7.624 per share on 5 December 2018. Following this transaction Mr Hayes holds  12,212 ordinary shares in the Company.

The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Hayes

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

 

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Acquisition

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£7.656

1,000

 


 

£7.613

2,000

 


 

£7.613

1,000

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

4,000



- Price

£7.624



e)

 

Date of the transaction

 

 

2018-12-05

f)

 

Place of the transaction

 

 

London Stock Exchange XLON

 

Enquiries: Michelle Palmer, Assistant Company Secretary 01442 8867920


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHDQLFBVLFFFBE

a d v e r t i s e m e n t